Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J. Zost, James E. Crowe, Pavlo Gilchuk et al.|Nature|2020Cited by 1.2k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J. Zost, James E. Crowe, Pavlo Gilchuk et al.|Nature Medicine|2020Cited by 543
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C. Chen, James E. Crowe, Pavlo Gilchuk et al.|Cell Reports|2021Cited by 114
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J. Zost, James E. Crowe, Pavlo Gilchuk et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 60
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J. Zost, James E. Crowe, Pavlo Gilchuk et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 51